JPM22: New Johnson & Johnson CEO Duato points out 5 pipeline meds that can generate $5B+

JPM22: New Johnson & Johnson CEO Duato points out 5 pipeline meds that can generate $5B+
esagonowsky
Mon, 01/10/2022 – 11:25